VEG113387 PROTECT
Laufzeit: 01.01.2011 - 31.12.2020
Kurzfassung
A randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy and safety of pazopanib as adjuvant therapy for subjects with localized or locally advanced RCC following nephrectomy
Beteiligte Einrichtungen
